Farms.com Home   News

Should I Liquidate the Herd While the Cattle Market is Strong?

By Dr. Andrew Griffith

This week a question was asked concerning liquidating the cow herd while the cattle market is strong. This is not the first time I have received this question as several producers have certainly entertained the thought.

The answer or the correct move for an individual producer is dependent on expectations, goals, longevity in the business, and alternative land uses if the land the cattle are on is owned. One thought some should consider is that the cattle market is expected to stay high for three years. If a person can stand to stay in business for a couple of years then it may be a wise decision to capitalize on a couple or three of years of strong calf prices and slowly market a few cows without keeping any heifers as replacements. This will result in taking advantage of the market while reducing the herd size. The producer can then reevaluate the alternative in year three and determine if liquidating the herd completely is still in the best interest of all parties.

Tax implications should also be considered when making this decision.

Source : osu.edu

Trending Video

Intrauterine Vaccines in Swine - Dr. Heather Wilson

Video: Intrauterine Vaccines in Swine - Dr. Heather Wilson



In this episode of The Swine it Podcast Show Canada, Dr. Heather Wilson from VIDO at the University of Saskatchewan explains how intrauterine vaccination is being developed as a new option for swine health. She shares how formulation, adjuvants, and delivery methods influence immune responses and what early trials reveal about safety and reproductive performance. Listen now on all major platforms.

"The idea was that an intrauterine vaccine might avoid a tolerance response and instead create an active immune response."

Meet the guest: Dr. Heather Wilson / heather-wilson-a8043641 is a Senior Scientist and Program Manager at the Vaccine and Infectious Disease Organization at the University of Saskatchewan. Her work centers on vaccine formulation and delivery in pigs, including the development of intrauterine vaccination to support reproductive health and passive protection of piglets. Her background spans biochemistry, immunology, and functional pathogenomics.